| Date | Title | Description |
| 19.08.2020 | Kronos Bio Appoints Dr. Yasir Al-Wakeel as Chief Financial O... | - |
| 16.07.2020 | Kronos Bio and Gilead Sciences Enter Into Asset Purchase Agr... | - |
| 19.12.2019 | Harvard taps Tishman Speyer to manage first phase of its new... | - |
| 19.12.2019 | UroGen Pharma Announces FDA Filing Acceptance and Priority R... | - |
| 20.11.2019 | Kronos Bio Appoints Biopharma Industry Veteran Jorge F. DiMa... | - |
| 11.11.2019 | UroGen Pharma Announces Exclusive License Agreement with Age... | - |
| 06.11.2019 | Allogene Therapeutics Announces Pre-Clinical Data Presentati... | - |
| 05.11.2019 | Allogene Therapeutics and Notch Therapeutics Announce Collab... | - |
| 24.10.2019 | Kronos Bio Strengthens Senior Management Team with New Leade... | - |
| 24.09.2019 | UroGen Reports Positive Data from Two Important Studies: UGN... | - |
| 24.09.2019 | UroGen Investor Day Details Positive Clinical Updates, UGN-1... | - |
| 19.09.2019 | Allogene Therapeutics Enters Research Collaboration Directed... | - |
| 07.08.2019 | Kronos Bio Expands Scientific Advisory Board with Addition o... | - |
| 05.08.2019 | Allogene Therapeutics Appoints Rafael G. Amado, M.D. as Exec... | - |
| 18.07.2019 | Kronos Bio Completes $105 Million Series A Financing | - |
| 16.07.2019 | Tishman Speyer and Bellco Capital Launch Breakthrough Proper... | - |
| 04.06.2019 | Allogene Therapeutics Announces FDA Clearance of the IND for... | - |
| 01.05.2019 | Allogene Therapeutics Announces Expansion of Scientific Advi... | - |
| 15.04.2019 | Allogene Therapeutics Announces Publication of Preclinical S... | - |
| 28.01.2019 | Allogene Therapeutics, in Collaboration with Servier, Announ... | - |
| 08.01.2019 | UroGen Pharma Announces Positive Results of UGN-101 from Piv... | - |
| 03.01.2019 | UroGen Pharma Appoints Elizabeth (Liz) Barrett as President ... | - |
| 04.12.2018 | Allogene Therapeutics Presents Data from Preclinical Study o... | - |
| 28.11.2018 | Kronos Bio Appoints Philip Gutry as Chief Business Officer t... | - |
| 15.10.2018 | Allogene Therapeutics Announces Closing of Initial Public Of... | - |
| 10.10.2018 | Allogene Therapeutics Announces Pricing of Initial Public Of... | - |
| 02.10.2018 | FierceBiotech names Kronos Bio as one of its “Fierce 15” Bio... | - |
| 27.09.2018 | Allogene Therapeutics Appoints Deborah M. Messemer, Former K... | - |
| 14.09.2018 | Allogene Therapeutics Announces Filing of Registration State... | - |
| 06.09.2018 | Allogene Therapeutics Completes a $120 Million Private Finan... | - |
| 28.08.2018 | Allogene Therapeutics Appoints David M. Tillett, Ph.D., as S... | - |
| 14.08.2018 | Allogene Therapeutics Appoints Susie Jun, M.D., Ph.D., as Ch... | - |
| 11.07.2018 | Allogene Therapeutics Announces Scientific Advisory Board | - |
| 18.06.2018 | Allogene Therapeutics Announces Eric T. Schmidt, Ph.D. as Ch... | - |
| 05.06.2018 | UroGen Pharma Announces Stephen Mullennix as Interim Chief F... | - |
| 04.06.2018 | Allogene Therapeutics Appoints Alison Moore, Ph.D. as Chief ... | - |
| 30.05.2018 | Allogene Therapeutics Announces Board of Directors | - |
| 23.05.2018 | Kronos Bio Appoints Dr. Norbert Bischofberger, Former Head o... | - |
| 21.05.2018 | UroGen Pharma Announces Positive Interim Results from Pivota... | - |
| 16.05.2018 | Sienna Biopharmaceuticals to Present SNA-125 Pre-Clinical Ps... | - |
| 15.05.2018 | Kite Announces New Worldwide Facilities and Expanded Collabo... | - |
| 03.04.2018 | Cellectis and Allogene Therapeutics Intend to Continue Strat... | - |
| 12.03.2018 | Sienna Biopharmaceuticals announces First Patient Dosed in P... | - |
| 22.02.2018 | New Published Study Reports Cardiosphere-Derived Cells Impro... | - |
| 22.02.2018 | Kite, a Gilead Company, and Sangamo Therapeutics Announce Co... | - |
| 14.02.2018 | UroGen Pharma Strengthens Management Team with the Appointme... | - |
| 14.02.2018 | Sienna Biopharmaceuticals announces First Patient Dosed in F... | - |
| 05.02.2018 | Capricor Receives FDA Regenerative Medicine Advanced Therapy... | - |
| 30.01.2018 | Hubble Contacts Launches Subscription Service in the UK | - |
| 23.01.2018 | UroGen Pharma Announces Closing of Upsized Public Offering o... | - |
| 18.01.2018 | Kite Announces Clinical Collaboration to Evaluate Investigat... | - |
| 16.01.2018 | Capricor Announces Licensing of Additional Patent Applicatio... | - |
| 08.01.2018 | UroGen Pharma Appoints Former Kite Pharma Executive Christin... | - |
| 12.12.2017 | UroGen Pharma Expands Clinical Development Leadership Team | - |
| 11.12.2017 | Kite Announces Data From ZUMA-3 Study of KTE-C19 in Adult Pa... | - |
| 10.12.2017 | Kite Announces Long-Term Data From Pivotal ZUMA-1 Study of Y... | - |
| 07.12.2017 | Gilead Sciences and Kite to Acquire Cell Design Labs | - |
| 29.11.2017 | Capricor Therapeutics Announces FDA Clearance of Investigati... | - |
| 15.11.2017 | Significant Improvements Reported in Duchenne Muscular Dystr... | - |
| 06.11.2017 | UroGen Pharma Announces First Patient Enrolled in Allergan P... | - |
| 02.11.2017 | UroGen Pharma Appoints Former Kite Pharma Chief Operating Of... | - |
| 26.10.2017 | UroGen Pharma Expands Leadership Team, Appoints Industry Vet... | - |
| 24.10.2017 | Sienna Biopharmaceuticals announces First Patient Dosed In P... | - |
| 18.10.2017 | Kite’s Yescarta™ (Axicabtagene Ciloleucel) Becomes First CAR... | - |
| 06.10.2017 | Capricor Therapeutics Reports Intravenous Administration of ... | - |
| 04.10.2017 | Capricor Therapeutics Presents Positive Six-Month Results in... | - |
| 03.10.2017 | Gilead Sciences Completes Acquisition of Kite Pharma, Inc. | - |
| 06.09.2017 | UroGen Pharma Strengthens Management Team with the Appointme... | - |
| 29.08.2017 | UroGen Pharma Receives FDA Fast Track Designation for MitoGe... | - |
| 28.08.2017 | Hubble Contacts Closes Series A-III Financing to Support Glo... | - |
| 28.08.2017 | Gilead Sciences to Acquire Kite Pharma for $11.9 Billion | - |
| 08.08.2017 | Kite Submits Investigational New Drug (IND) Application for ... | - |
| 03.08.2017 | Kite Announces Landmark Study of Refractory Aggressive Non-H... | - |
| 01.08.2017 | Sienna Biopharmaceuticals Announces Closing of Initial Publi... | - |
| 01.08.2017 | Cell Design Labs Appoints Roger Sidhu, M.D. As Chief Medical... | - |
| 31.07.2017 | Kite Files the Industry’s First CAR-T Marketing Authorizatio... | - |
| 26.07.2017 | Sienna Biopharmaceuticals, Inc. Announces Pricing of Initial... | - |
| 20.07.2017 | Kite Highlights Durable Complete Remissions Up to 56+ Months... | - |
| 19.07.2017 | Investigational New Drug Application for RTGel™ in Combinati... | - |
| 18.07.2017 | Capricor Receives Rare Pediatric Disease Designation from FD... | - |
| 27.06.2017 | Kite Named to the MIT Technology Review’s Annual 50 Smartest... | - |
| 14.06.2017 | Sienna Biopharmaceuticals Appoints Erle Mast, Former CFO and... | - |
| 07.06.2017 | Cell Design Labs Announces Issuance of Broad Patent for Chim... | - |
| 05.06.2017 | Kite Reports 73 Percent of Patients Achieved MRD Negative Co... | - |
| 26.05.2017 | Kite Receives U.S. Food and Drug Administration Priority Rev... | - |
| 16.05.2017 | UroGen Pharma Appoints Fred E. Cohen, MD, to its Board of Di... | - |
| 10.05.2017 | UroGen Pharma Announces Closing of Initial Public Offering a... | - |
| 08.05.2017 | Capricor Therapeutics Announces Private Placement of Common ... | - |
| 25.04.2017 | Capricor Therapeutics Announces Positive Six-Month Results f... | - |
| 24.04.2017 | UroGen Pharma Welcomes New Board Member Kate Falberg | - |
| 24.04.2017 | Sienna Biopharmaceuticals Announces $40 Million Series B Fin... | - |
| 06.04.2017 | Kite Wins ‘Clinical Trial Result of the Year’ for its Pivota... | - |
| 03.04.2017 | UroGen Pharma Announces Enrollment of First Patient in Phase... | - |
| 02.04.2017 | Kite Presents Ongoing Response Rate in Plenary Session from ... | - |
| 31.03.2017 | Kite Completes Submission of U.S. Biologics License Applicat... | - |
| 31.03.2017 | New Gene Therapy for Cancer Offers Hope to Those With No Opt... | - |
| 24.03.2017 | Richard Peterson Joins Sienna Biopharmaceuticals As Chief Fi... | - |
| 20.03.2017 | Hubble Contacts Wants To Do For Contact Lenses What Harry’s ... | - |
| 15.03.2017 | Cell Design Labs Announces Issuance of a Broad Patent for Pr... | - |
| 14.03.2017 | Kite Pharma Highlights Publication from the National Cancer ... | - |